Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

SERA

Sera Prognostics Inc

Jan 21 • 04:00PM ET

6.64

Dollar change +0.22
Percentage change 3.43	%

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA GH BIO EXAS ONC CDNA QDEL RCKT VERU

| Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL DFAS AVSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.99	Insider Own	36.94%	Shs Outstand	32.77M	Perf Week	4.90%
Market Cap	224.25M	Forward P/E	-	EPS next Y	-1.00	Insider Trans	-1.85%	Shs Float	21.40M	Perf Month	-19.12%
Income	-32.24M	PEG	-	EPS next Q	-0.24	Inst Own	48.62%	Short Float	4.92%	Perf Quarter	-13.88%
Sales	0.09M	P/S	2491.67	EPS this Y	15.74%	Inst Trans	2.65%	Short Ratio	10.26	Perf Half Y	-14.87%
Book/sh	1.62	P/B	4.10	EPS next Y	-2.06%	ROA	-38.15%	Short Interest	1.05M	Perf Year	11.04%
Cash/sh	1.47	P/C	4.51	EPS next 5Y	-	ROE	-49.58%	52W Range	4.98 - 12.35	Perf YTD	-18.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-21.21%	ROI	-58.82%	52W High	-46.26%	Beta	0.83
Dividend TTM	-	Quick Ratio	2.11	Sales past 5Y	109.61%	Gross Margin	-996.81%	52W Low	33.33%	ATR (14)	0.59
Dividend Ex-Date	-	Current Ratio	2.11	EPS Y/Y TTM	19.00%	Oper. Margin	-38237.23%	RSI (14)	40.96	Volatility	6.86% 8.03%
Employees	57	Debt/Eq	0.02	Sales Y/Y TTM	-71.52%	Profit Margin	-34302.13%	Recom	1.67	Target Price	2.75
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-2.52%	Payout	-	Rel Volume	0.58	Prev Close	6.42
Sales Surprise	-66.63%	EPS Surprise	-9.44%	Sales Q/Q	-30.95%	Earnings	Nov 06 AMC	Avg Volume	102.73K	Price	6.64
SMA20	-12.73%	SMA50	-9.62%	SMA200	-14.67%	Trades		Volume	59,789	Change	3.43%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-30-22	Downgrade	Citigroup	Buy → Neutral	$18 → $4
Nov-19-21	Initiated	Oppenheimer	Outperform	$19
Oct-15-21	Resumed	Cowen	Outperform

Jan-06-25 08:30AM	Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-04-24 04:01PM	Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting (PR Newswire) +14.78%
Dec-02-24 08:30AM	Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference (PR Newswire)
Nov-26-24 05:00AM	5 investing trends for 2025and 15 stocks to help you bet on them (Fortune)
Nov-15-24 08:30AM	Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
06:00PM	Loading…
Nov-06-24 06:00PM	Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +14.25% -12.70%
04:05PM	SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Oct-28-24 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024 (PR Newswire)
Sep-04-24 04:53PM	Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire)
Aug-08-24 08:30AM	Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 (PR Newswire)
Aug-07-24 05:50PM	Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Jul-25-24 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 (PR Newswire)
Jul-09-24 08:30AM	Sera Prognostics PreTRM Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial (PR Newswire)
Jul-01-24 08:30AM	SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION (PR Newswire)
06:17AM	Loading…
Jun-16-24 06:17AM	3 Stocks Under $10 With the Potential to Make You a Millionaire (InvestorPlace)
May-28-24 08:30AM	SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES (PR Newswire)
May-10-24 03:10PM	Sera Prognostics Inc Reports Q1 2024 Results: A Closer Look at Financials and Strategic Moves (GuruFocus.com) -5.41%
May-09-24 10:44AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.27%
May-08-24 08:57PM	SERA Stock Earnings: Sera Prognostics Beats EPS for Q1 2024 (InvestorPlace)
04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Apr-29-24 02:15PM	Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024 (PR Newswire)
Mar-29-24 01:32AM	Chief Scientific Officer John Boniface Sells 77,136 Shares of Sera Prognostics Inc (SERA) (GuruFocus.com)
Mar-27-24 01:27AM	Chief Scientific Officer John Boniface Sells 22,163 Shares of Sera Prognostics Inc (SERA) (GuruFocus.com)
Mar-25-24 12:00PM	Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know (Zacks) -8.50%
Mar-21-24 09:57AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-20-24 08:54PM	SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:33PM	Sera Prognostics Inc Reports Modest Revenue Growth Amid Operational Streamlining (GuruFocus.com)
05:20PM	Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
11:40AM	Loading…
Mar-12-24 11:40AM	25 Countries With Highest Abortion Rates (Insider Monkey)
Mar-04-24 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024 (PR Newswire)
Feb-29-24 11:14AM	Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference (PR Newswire)
Dec-11-23 12:00PM	Here's Why Sera Prognostics, Inc. (SERA) is a Great Momentum Stock to Buy (Zacks)
Dec-06-23 01:19PM	Why Is Sera Prognostics (SERA) Stock Up 260% Today? (InvestorPlace) +161.43%
08:30AM	SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS (PR Newswire)
Nov-22-23 01:00PM	SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE (PR Newswire)
Nov-12-23 10:59AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 06:29PM	Sera Prognostics Inc (SERA) Reports Q3 2023 Financial Results: Revenue Declines as Cost ... (GuruFocus.com) -7.61%
04:05PM	SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Oct-25-23 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023 (PR Newswire) +6.06%
Sep-21-23 08:30AM	SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023 (PR Newswire)
Aug-31-23 09:35AM	Sera Prognostics, Inc. (SERA) Loses -32.38% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -6.32%
Aug-30-23 09:35AM	Sera Prognostics, Inc. (SERA) Loses -38.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-09-23 05:50PM	Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Jul-31-23 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023 (PR Newswire)
May-25-23 04:15PM	Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue (PR Newswire) -5.08%
May-15-23 05:15PM	Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO (PR Newswire)
May-10-23 06:05PM	Sera Prognostics, Inc. (SERA) Reports Q1 Loss (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
May-04-23 07:31AM	We're Not Very Worried About Sera Prognostics' (NASDAQ:SERA) Cash Burn Rate (Simply Wall St.)
Apr-27-23 08:30AM	Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023 (PR Newswire)
Apr-24-23 09:35AM	Sera Prognostics, Inc. (SERA) Loses -13.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-27-23 12:00PM	All You Need to Know About Sera Prognostics, Inc. (SERA) Rating Upgrade to Buy (Zacks)
02:27AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-24-23 06:29AM	Sera Prognostics Full Year 2022 Earnings: Revenues Miss Expectations (Simply Wall St.)
Mar-22-23 05:35PM	Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -6.77%
04:05PM	SERA PROGNOSTICS REPORTS FOURTH QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Mar-09-23 04:05PM	Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023 (PR Newswire)
Feb-23-23 04:20PM	SERA PROGNOSTICS TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES (PR Newswire) -7.22%
Feb-18-23 07:43AM	Individual investors in Sera Prognostics, Inc. (NASDAQ:SERA) are its biggest bettors, and their bets paid off as stock gained 179% last week (Simply Wall St.)
Feb-15-23 08:30AM	Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL (PR Newswire) +73.28%
Nov-29-22 08:30AM	FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS (PR Newswire) -7.63%
Nov-15-22 08:30AM	SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS (PR Newswire)
Nov-09-22 06:15PM	Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +10.77%
04:05PM	SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Nov-04-22 04:00PM	Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9 (PR Newswire) -10.37%
Oct-04-22 08:30AM	SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS (PR Newswire) +7.78%
Sep-22-22 08:30AM	BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS (PR Newswire)
Sep-20-22 07:19AM	Is Sera Prognostics (NASDAQ:SERA) In A Good Position To Invest In Growth? (Simply Wall St.)
Aug-11-22 07:00AM	Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-10-22 05:55PM	Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -6.64%
04:05PM	SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Aug-03-22 10:00AM	Sera Prognostics, Inc. (SERA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-28-22 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10 (PR Newswire)
Jun-06-22 02:15PM	SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE (PR Newswire)
May-19-22 04:15PM	SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING IMPROVED PERFORMANCE OF ITS PRETRM® TEST WITH MORE PRECISE GESTATIONAL AGE (PR Newswire)
May-18-22 03:03PM	SERA PROGNOSTICS PRESENTS DATA DEMONSTRATING THE HEALTH AND ECONOMIC BENEFIT OF PRETRM® TESTING AT ISPOR ANNUAL MEETING (PR Newswire)
May-10-22 04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS (PR Newswire) -7.11%
May-05-22 08:30AM	SERA PROGNOSTICS AND NEWBORN FOUNDATION PARTNER TO REDUCE RISKS ASSOCIATED WITH PRETERM BIRTH AND IMPROVE HEALTH EQUITY THROUGH THE "EVERY MOTHER, EVERY BABY" PROJECT (PR Newswire)
May-02-22 08:30AM	Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 (PR Newswire)
Apr-12-22 08:30AM	SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF DR. JANE F. BARLOW TO THE SERA PROGNOSTICS BOARD (PR Newswire) -11.31%
Mar-30-22 07:30AM	Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Call Transcript (Motley Fool) -7.65%
Mar-29-22 04:00PM	SERA PROGNOSTICS REPORTS FOURTH QUARTER 2021 FINANCIAL RESULTS (PR Newswire) +12.19%
Mar-18-22 12:00PM	Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting (PR Newswire) -14.45%
07:00AM	Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2021 Financial Results on March 29 (PR Newswire)
Mar-03-22 08:30AM	SERA PROGNOSTICS TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES (PR Newswire) -6.05%
Feb-17-22 08:30AM	SERA PROGNOSTICS PRESENTATION RESCHEDULED FOR CITI 2022 HEALTHCARE CONFERENCE (PR Newswire)
Feb-07-22 08:30AM	SERA PROGNOSTICS TO PRESENT AT UPCOMING FEBRUARY INVESTOR CONFERENCES (PR Newswire)
Feb-01-22 08:30AM	SERA PROGNOSTICS ANNOUNCES NEW AGREEMENT WITH MULTIPLAN, EXPANDING PATIENT ACCESS TO THE PRETRM® TEST (PR Newswire)
Dec-15-21 08:30AM	SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX (PR Newswire)
Dec-02-21 08:00AM	Sera Prognostics Announces Pricing For PreTRM® Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth (PR Newswire)
Dec-01-21 11:40AM	Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations (PR Newswire)
Nov-30-21 08:00AM	Sera Prognostics Announces The Appointment Of Sandra A.J. Lawrence To The Sera Prognostics Board (PR Newswire)
Nov-10-21 09:01AM	Sera Prognostics, Inc. (SERA) Q3 2021 Earnings Call Transcript (Motley Fool)
Nov-09-21 04:01PM	Sera Prognostics Reports Third Quarter 2021 Financial Results (PR Newswire)
Nov-08-21 04:20PM	Sera Prognostics Announces The Appointment Of Zhenya Lindgardt To The Board (PR Newswire)
Nov-04-21 08:00AM	Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs (PR Newswire) +5.63%
Nov-03-21 08:00AM	Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action (PR Newswire)

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Phillips Joshua	Director	Jan 10 '25	Sale	7.40	12,710	94,011	5	Jan 14 09:56 PM
Phillips Joshua	Director	Jan 13 '25	Sale	6.39	12,163	77,722	2	Jan 14 09:56 PM
Phillips Joshua	Director	Jan 14 '25	Sale	6.29	9,338	58,736	0	Jan 14 09:56 PM
Jackson Benjamin	General Counsel	Jan 10 '25	Sale	7.42	13,272	98,531	128,473	Jan 14 09:13 PM
Jackson Benjamin	General Counsel	Jan 14 '25	Sale	6.20	8,407	52,123	112,154	Jan 14 09:13 PM
Jackson Benjamin	General Counsel	Jan 13 '25	Sale	6.38	7,912	50,479	120,561	Jan 14 09:13 PM
Harrison Robert Gardner	Chief Information Officer	Jan 10 '25	Sale	7.39	14,209	105,030	116,837	Jan 14 09:12 PM
Harrison Robert Gardner	Chief Information Officer	Jan 13 '25	Sale	6.47	2,264	14,648	114,573	Jan 14 09:12 PM
Kearney Paul	Chief Data Officer	Jan 10 '25	Sale	7.42	13,419	99,565	163,470	Jan 14 09:11 PM
Aerts Austin	Chief Financial Officer	Jan 10 '25	Sale	8.06	2,431	19,594	283,325	Jan 14 09:11 PM
Catalyst Health Ventures Follo	Shareholder	Jan 10 '25	Proposed Sale	8.32	8	67		Jan 10 05:34 PM
CHV Investments, LLC (Pool 4)	Shareholder	Jan 10 '25	Proposed Sale	8.32	8,562	71,236		Jan 10 05:32 PM
CHV Investments, LLC (Pool 11)	Shareholder	Jan 10 '25	Proposed Sale	8.32	5,320	44,262		Jan 10 05:30 PM
CHV Investments, LLC (Pool 17)	Shareholder	Jan 10 '25	Proposed Sale	8.32	3,232	26,890		Jan 10 05:30 PM
CHV Investments, LLC (Pool 21)	Shareholder	Jan 10 '25	Proposed Sale	8.32	570	4,742		Jan 10 05:29 PM
Catalyst Health Ventures (PF),	Shareholder	Jan 10 '25	Proposed Sale	8.32	9,726	80,920		Jan 10 05:29 PM
CATALYST HEALTH VENTURES LP	Shareholder	Jan 10 '25	Proposed Sale	8.32	6,793	56,518		Jan 10 05:28 PM
AUSTIN AERTS	Officer	Jan 10 '25	Proposed Sale	8.32	20,000	166,400		Jan 10 04:23 PM
PAUL KEARNEY	Officer	Jan 10 '25	Proposed Sale	8.32	52,231	434,562		Jan 10 04:22 PM
ROBERT HARRISON	Officer	Jan 10 '25	Proposed Sale	8.32	16,473	137,055		Jan 10 04:22 PM
BENJAMIN JACKSON	Officer	Jan 10 '25	Proposed Sale	8.32	45,285	376,771		Jan 10 04:21 PM
Mirza Mansoor Raza	Director	Jan 06 '25	Proposed Sale	7.59	100	759		Jan 07 04:05 PM
Mirza Mansoor Raza	Director	Jan 06 '25	Sale	7.69	100	769	6,536	Jan 07 04:05 PM
Lindgardt Zhenya	Officer	Dec 10 '24	Proposed Sale	7.41	26,224	194,396		Dec 12 04:36 PM
Aerts Austin	Officer	Dec 10 '24	Proposed Sale	7.41	5,730	42,476		Dec 12 04:36 PM
Lindgardt Zhenya	Chief Executive Officer	Dec 10 '24	Sale	7.41	26,224	194,320	793,534	Dec 12 04:35 PM
Aerts Austin	Chief Financial Officer	Dec 10 '24	Sale	7.41	5,730	42,459	285,756	Dec 12 04:35 PM
Mirza Mansoor Raza	Director	Dec 06 '24	Sale	7.12	93	662	6,636	Dec 09 04:52 PM
Mirza Mansoor Raza	Director	Dec 06 '24	Proposed Sale	7.12	93	662		Dec 09 04:50 PM
Lindgardt Zhenya	Officer	Nov 11 '24	Proposed Sale	7.32	12,075	88,331		Nov 13 04:05 PM
Aerts Austin	Officer	Nov 11 '24	Proposed Sale	7.32	7,179	52,516		Nov 13 04:05 PM
Boniface John J.	Officer	Nov 11 '24	Proposed Sale	7.32	4,727	34,579		Nov 13 04:05 PM
Kearney Paul	Officer	Nov 11 '24	Proposed Sale	7.32	4,078	29,831		Nov 13 04:05 PM
Harrison Robert Gardner	Officer	Nov 11 '24	Proposed Sale	7.32	4,727	34,579		Nov 13 04:05 PM
Jackson Benjamin	Officer	Nov 11 '24	Proposed Sale	7.32	4,727	34,579		Nov 13 04:05 PM
Mirza Mansoor Raza	Director	Nov 11 '24	Proposed Sale	7.26	95	690		Nov 13 04:05 PM
Mirza Mansoor Raza	Director	Nov 11 '24	Sale	7.32	95	695	6,729	Nov 12 05:05 PM
Lindgardt Zhenya	Chief Executive Officer	Nov 11 '24	Sale	7.32	12,075	88,389	819,758	Nov 12 05:05 PM
Kearney Paul	Chief Data Officer	Nov 11 '24	Sale	7.32	4,078	29,851	176,889	Nov 12 05:04 PM
Jackson Benjamin	General Counsel	Nov 11 '24	Sale	7.32	4,727	34,602	135,528	Nov 12 05:04 PM
Harrison Robert Gardner	Chief Information Officer	Nov 11 '24	Sale	7.32	4,727	34,602	131,046	Nov 12 05:03 PM
Boniface John J.	Chief Scientific Officer	Nov 11 '24	Sale	7.32	4,727	34,602	125,120	Nov 12 05:03 PM
Aerts Austin	Chief Financial Officer	Nov 11 '24	Sale	7.32	7,179	52,550	291,486	Nov 12 05:02 PM
Mirza Mansoor Raza	Director	Oct 07 '24	Proposed Sale	7.04	96	676		Oct 07 06:22 PM
Mirza Mansoor Raza	Director	Oct 07 '24	Sale	7.15	96	686	6,824	Oct 07 06:22 PM
Lindgardt Zhenya	Officer	Sep 10 '24	Proposed Sale	7.57	25,085	189,876		Sep 11 05:45 PM
Aerts Austin	Officer	Sep 10 '24	Proposed Sale	7.57	5,056	38,270		Sep 11 05:44 PM
Aerts Austin	Chief Financial Officer	Sep 10 '24	Sale	7.57	5,056	38,274	298,665	Sep 10 04:55 PM
Lindgardt Zhenya	Chief Executive Officer	Sep 10 '24	Sale	7.57	25,085	189,893	831,833	Sep 10 04:55 PM
Mirza Mansoor Raza	Director	Sep 06 '24	Proposed Sale	7.05	96	677		Sep 09 04:50 PM
Mirza Mansoor Raza	Director	Sep 06 '24	Sale	7.16	96	687	6,920	Sep 09 04:46 PM
Lindgardt Zhenya	Officer	Aug 07 '24	Proposed Sale	7.42	12,327	91,405		Aug 08 05:07 PM
Harrison Robert Gardner	Officer	Aug 07 '24	Proposed Sale	7.41	5,022	37,238		Aug 08 05:05 PM
Kearney Paul	Officer	Aug 07 '24	Proposed Sale	7.41	4,333	32,129		Aug 08 05:04 PM
Mirza Mansoor Raza	Director	Aug 07 '24	Proposed Sale	7.42	101	749		Aug 08 05:02 PM
Boniface John J.	Officer	Aug 07 '24	Proposed Sale	7.41	5,022	37,238		Aug 08 05:01 PM
Jackson Benjamin	Officer	Aug 07 '24	Proposed Sale	7.41	5,022	37,238		Aug 08 05:00 PM
Aerts Austin	Officer	Aug 07 '24	Proposed Sale	7.41	6,760	50,125		Aug 08 04:58 PM
Boniface John J.	Chief Scientific Officer	Aug 07 '24	Sale	7.42	5,022	37,263	129,847	Aug 08 04:51 PM
Harrison Robert Gardner	Chief Information Officer	Aug 07 '24	Sale	7.42	5,022	37,263	135,773	Aug 08 04:50 PM
Kearney Paul	Chief Data Officer	Aug 07 '24	Sale	7.42	4,333	32,151	180,967	Aug 08 04:50 PM
Lindgardt Zhenya	Chief Executive Officer	Aug 07 '24	Sale	7.42	12,327	91,466	856,918	Aug 08 04:50 PM
Mirza Mansoor Raza	Director	Aug 07 '24	Sale	7.42	101	749	7,016	Aug 08 04:50 PM
Jackson Benjamin	General Counsel	Aug 07 '24	Sale	7.42	5,022	37,263	140,255	Aug 08 04:50 PM
Aerts Austin	Chief Financial Officer	Aug 07 '24	Sale	7.42	6,760	50,159	303,721	Aug 08 04:49 PM
Lindgardt Zhenya	Chief Executive Officer	Jun 10 '24	Sale	8.11	26,867	217,891	869,245	Jun 11 04:50 PM
Aerts Austin	Chief Financial Officer	Jun 10 '24	Sale	8.11	5,415	43,916	310,481	Jun 11 04:50 PM
Kearney Paul	Chief Data Officer	May 15 '24	Sale	8.24	10,387	85,589	185,300	May 15 06:23 PM
Kearney Paul	Chief Data Officer	May 08 '24	Sale	9.59	4,205	40,326	154,833	May 10 05:42 PM
Boniface John J.	Chief Scientific Officer	May 08 '24	Sale	9.59	4,902	47,010	134,869	May 10 05:41 PM
Jackson Benjamin	General Counsel	May 08 '24	Sale	9.59	4,902	47,010	145,277	May 10 05:41 PM
Aerts Austin	Chief Financial Officer	May 08 '24	Sale	9.59	6,592	63,217	315,896	May 10 05:41 PM
Lindgardt Zhenya	Chief Executive Officer	May 08 '24	Sale	9.59	11,992	115,003	896,112	May 10 05:41 PM
Harrison Robert Gardner	Chief Information Officer	May 08 '24	Sale	9.59	4,902	47,010	140,795	May 10 05:40 PM
Boniface John J.	Chief Scientific Officer	Mar 27 '24	Option Exercise	0.91	48,909	44,507	188,680	Mar 28 05:56 PM
Boniface John J.	Chief Scientific Officer	Mar 28 '24	Option Exercise	0.91	24,474	22,271	164,245	Mar 28 05:56 PM
Boniface John J.	Chief Scientific Officer	Mar 27 '24	Sale	9.62	52,662	506,608	139,771	Mar 28 05:56 PM
Boniface John J.	Chief Scientific Officer	Mar 28 '24	Sale	9.04	24,474	221,245	139,771	Mar 28 05:56 PM
Lindgardt Zhenya	Chief Executive Officer	Mar 26 '24	Sale	9.37	38,899	364,484	908,104	Mar 26 08:00 PM
Aerts Austin	Chief Financial Officer	Mar 26 '24	Sale	9.37	8,092	75,822	322,488	Mar 26 08:00 PM
Boniface John J.	Chief Scientific Officer	Mar 26 '24	Sale	9.55	21,438	204,733	143,524	Mar 26 05:38 PM
Boniface John J.	Chief Scientific Officer	Mar 25 '24	Sale	9.10	22,163	201,683	164,962	Mar 26 04:20 PM
Boniface John J.	Chief Scientific Officer	Mar 06 '24	Sale	9.02	1,664	15,009	187,125	Mar 07 04:16 PM
Aerts Austin	Chief Financial Officer	Mar 06 '24	Sale	9.02	444	4,005	330,580	Mar 07 04:16 PM
Kearney Paul	Chief Data Officer	Mar 06 '24	Sale	9.02	1,028	9,273	159,038	Mar 07 04:16 PM
Harrison Robert Gardner	Chief Information Officer	Mar 06 '24	Sale	9.02	2,138	19,285	145,697	Mar 07 04:15 PM
Jackson Benjamin	General Counsel	Mar 06 '24	Sale	9.02	1,856	16,741	150,179	Mar 07 04:15 PM
Jackson Benjamin	General Counsel	Feb 06 '24	Sale	8.03	5,665	45,490	152,035	Feb 07 04:57 PM
Boniface John J.	Chief Scientific Officer	Feb 06 '24	Sale	8.03	5,665	45,490	188,789	Feb 07 04:57 PM
Kearney Paul	Chief Data Officer	Feb 06 '24	Sale	8.03	4,984	40,022	160,066	Feb 07 04:56 PM
Harrison Robert Gardner	Chief Information Officer	Feb 06 '24	Sale	8.03	5,665	45,490	147,835	Feb 07 04:56 PM
Lindgardt Zhenya	Chief Executive Officer	Feb 06 '24	Sale	8.03	27,997	224,816	947,003	Feb 07 04:56 PM
Aerts Austin	Chief Financial Officer	Feb 06 '24	Sale	8.03	9,786	78,582	331,024	Feb 07 04:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SERA

Sera Prognostics Inc

Upgrade your FINVIZ experience